Like ALKBH5, FTO is downregulated as a tumor suppressor in a variety of cancers, including BC (145), lung cancer (212), CRC (213), bladder cancer (214, 215), prostate cancer (216), ccRCC (181, 217, 218), and adrenocortical cancer (219). This evidence concerns the gene FTO and lung cancer.